Filing Details

Accession Number:
0001246360-17-002524
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-08 18:35:11
Reporting Period:
2017-08-07
Filing Date:
2017-08-08
Accepted Time:
2017-08-08 18:35:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341403 Jr E Joseph Turk 350 Merrimack Street
Lawrence MA 01843
President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-07 7,000 $11.03 82,903 No 4 M Direct
Common Stock Acquisiton 2017-08-07 12,000 $14.66 94,903 No 4 M Direct
Common Stock Acquisiton 2017-08-07 2,669 $18.48 97,572 No 4 M Direct
Common Stock Acquisiton 2017-08-07 2,331 $18.59 99,903 No 4 M Direct
Common Stock Disposition 2017-08-07 6,000 $29.66 93,903 No 4 S Direct
Common Stock Disposition 2017-08-07 18,000 $29.63 75,903 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-08-07 7,000 $0.00 7,000 $11.03
Common Stock Stock Option (Right to Buy) Disposition 2017-08-07 12,000 $0.00 12,000 $14.66
Common Stock Stock Option (Right to Buy) Disposition 2017-08-07 2,669 $0.00 2,669 $18.48
Common Stock Stock Option (Right to Buy) Disposition 2017-08-07 2,331 $0.00 2,331 $18.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,897 2013-04-04 2023-03-03 No 4 M Direct
36,958 2014-04-10 2024-03-09 No 4 M Direct
7,542 2012-04-09 2019-03-08 No 4 M Direct
5,392 2011-06-27 2018-05-26 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016.